Literature DB >> 24715277

Long-term follow-up and quality of life in patients with intracranial germinoma.

T Martens1, R Rotermund, C Zu Eulenburg, M Westphal, J Flitsch.   

Abstract

Intracranial germinomas are fairly rare tumors occurring mostly in children or young adults with a comparatively good prognosis. Radiation is the preferred treatment of choice for this diagnosis. It has been thoroughly studied to what extent radiation doses and fields can be limited in order to avoid side effects in these young patients. The role of chemotherapy remains unclear, whereas surgery is limited to biopsy for proof of histology. Regarding the good overall survival rate, quality of life is a significant aspect to consider in these patients. We present a single institution analysis of patients with intracranial germinoma and analyze the long-term outcome with special regard to quality of life. Thirty-three patients with intracranial germinomas were analyzed by chart review, telephone interview, and neurological assessment. Additionally, a survey on quality of life was performed. The 10-year overall survival rate was 82.1 % at a mean follow-up of 141 (22-306) months. Three quarters (76 %) of the patients reached a favorable neurological outcome on the Modified Rankin Scale (mRS 0-2). However, the self-reported quality of life was significantly worse in germinoma patients compared with a healthy control group (p < 0.001). Surgical resection of the tumor led to no improvement regarding overall survival, neurological outcome, and quality of life. In terms of cognitive functioning, patients with tumor resection were significantly more impaired than biopsied patients (p = 0.04). Although germinomas are efficiently treatable tumors, the restrictions in quality of life in these often young patients are considerable, including financial difficulties. There seems no justification for tumor resection in newly diagnosed cases suspicious for germinoma as the cognitive outcome is worse than in biopsied patients, and there is no effect on overall survival.

Entities:  

Mesh:

Year:  2014        PMID: 24715277     DOI: 10.1007/s10143-014-0544-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  29 in total

1.  Management of primary intracranial germinomas: diagnostic surgery or radical resection?

Authors:  Y Sawamura; N de Tribolet; N Ishii; H Abe
Journal:  J Neurosurg       Date:  1997-08       Impact factor: 5.115

2.  Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure.

Authors:  Quynh-Nhu Nguyen; Eric L Chang; Pamela K Allen; Moshe H Maor; Joann L Ater; Anita Mahajan; Johannes E A Wolff; Jeffrey S Weinberg; Shiao Y Woo
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

3.  Optimal treatment for intracranial germinoma: can we lower radiation dose without chemotherapy?

Authors:  Sang-Hue Yen; Yi-Wei Chen; Pin-I Huang; Tai-Tong Wong; Donald Ming-Tak Ho; Kai-Ping Chang; Muh-Lii Liang; Shih-Hwa Chiou; Yi-Yen Lee; Hsin-Hung Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-26       Impact factor: 7.038

4.  Surgery for primary CNS lymphoma? Challenging a paradigm.

Authors:  Michael Weller; Peter Martus; Patrick Roth; Eckhard Thiel; Agnieszka Korfel
Journal:  Neuro Oncol       Date:  2012-09-14       Impact factor: 12.300

5.  Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Jun Ikeda; Kenji Fujieda; Kazuo Miyasaka; Yutaka Sawamura
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

6.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

7.  Long term outcomes in patients with intracranial germinomas: a single institution experience of irradiation with or without chemotherapy.

Authors:  Yasuhiro Kawabata; Jun A Takahashi; Yoshiki Arakawa; Mitsuaki Shirahata; Nobuo Hashimoto
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

8.  Patterns of failure in patients with primary intracranial germinoma treated with neoadjuvant chemotherapy and radiotherapy.

Authors:  Peter Paximadis; Abhirami Hallock; Kanta Bhambhani; Roland Chu; Sandeep Sood; Zhihong Wang; Andre Konski
Journal:  Pediatr Neurol       Date:  2012-09       Impact factor: 3.372

Review 9.  Intracranial germ-cell tumors: natural history and pathogenesis.

Authors:  M T Jennings; R Gelman; F Hochberg
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

10.  Intracranial germ cell tumors: a single institution experience and review of the literature.

Authors:  A A Smith; E Weng; M Handler; N K Foreman
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.130

View more
  9 in total

1.  Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer.

Authors:  Breanna E Lane; Sheila N Garland; Karine Chalifour; Geoff Eaton; Sophie Lebel; Jacqueline Galica; Christine Maheu; Sébastien Simard
Journal:  J Cancer Surviv       Date:  2019-08-29       Impact factor: 4.442

2.  Tumor immune microenvironment is associated with the growth of intracranial germinomas.

Authors:  Masaaki Nishimoto; Kentaro Ohara; Dai Kamamoto; Ryota Tamura; Tomoru Miwa; Kazunari Yoshida; Hikaru Sasaki
Journal:  J Neurooncol       Date:  2019-11-26       Impact factor: 4.130

3.  MRI and MR spectroscopy findings of the evolution of an intracranial germinoma: A case report.

Authors:  Jun Li; Xue-Yan Zhang; Bin Wang; Jun-Zu Geng
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

4.  The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors.

Authors:  Hideo Nakamura; Hirokazu Takami; Takaaki Yanagisawa; Toshihiro Kumabe; Takamitsu Fujimaki; Yoshiki Arakawa; Katsuyuki Karasawa; Keita Terashima; Hideaki Yokoo; Kohei Fukuoka; Yukihiko Sonoda; Kaori Sakurada; Yohei Mineharu; Toshinori Soejima; Motoaki Fujii; Naoki Shinojima; Junichi Hara; Kai Yamasaki; Junya Fujimura; Fumiyuki Yamasaki; Mayu Takahashi; Tomonari Suzuki; Iori Sato; Ryo Nishikawa; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

5.  Neurocognitive function, performance status, and quality of life in pediatric intracranial germ cell tumor survivors.

Authors:  Winnie Wan Yee Tso; Anthony Pak Yin Liu; Tatia Mei Chun Lee; Ka Leung Cheuk; Ming Kong Shing; Chung Wing Luk; Siu Cheung Ling; Dennis Tak Loi Ku; Kenneth Li; Ada Wing Yan Yung; Cheuk Wing Fung; Sophelia Hoi Shan Chan; Alvin Chi Chung Ho; Frederick Ka Wing Ho; Patrick Ip; Godfrey Chi Fung Chan
Journal:  J Neurooncol       Date:  2018-11-20       Impact factor: 4.130

6.  Bifocal germinoma in a patient with 16p11.2 microdeletion syndrome.

Authors:  Mara Ventura; Leonor Gomes; Joana Rosmaninho-Salgado; Luísa Barros; Isabel Paiva; Miguel Melo; Diana Oliveira; Francisco Carrilho
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-02-07

7.  Trends in cognitive dysfunction following surgery for intracranial tumors.

Authors:  Manju Dhandapani; Sandhya Gupta; Manju Mohanty; Sunil Kumar Gupta; Sivashanmugam Dhandapani
Journal:  Surg Neurol Int       Date:  2016-03-22

8.  Determining an Optimal Cutoff of Serum β-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas.

Authors:  Hui Zhang; Peng Zhang; Jun Fan; Binghui Qiu; Jun Pan; Xi'an Zhang; Luxiong Fang; Songtao Qi
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

9.  Endoscopic Transsphenoidal Approach in Treatment of Germinomas of the Chiasmosellar Region.

Authors:  Maxim Alexandrovich Kutin; Dmitry Vladislavovich Fomichev; Alexey Nikolaevich Shkarubo; Ilia Valerievich Chernov; Oleg Ildarovich Sharipov; Dmitry Nikolaevich Andreev; Denilbek Beksultanovich Ismailov; Nikita Igorevich Mikhailov; Grigoriy Lvovich Kobyakov; Yuriy Yurievich Trunin; Ludmila Igorevna Astafyeva; Abdishukur Abdilatipovich Abdilatipov; Artem Andreevich Poddubsky; Pavel Lvovich Kalinin
Journal:  Asian J Neurosurg       Date:  2019-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.